Co Dafiro
Amolodipine, hydrochlorothiazide, valsartan
Every registration of this product has been cancelled.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Registration
- Applicants
- 1
- Registrations
- 4
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Sandoz South Africa (Pty) LtdCancelled | Co dafiro | 5/160/12,5/25 mg, 5/160/25,0 mg, 10/160/12,5mg, 10/320/25 mg | 480877, 480878, 480879, 480881 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Co- dafiro 5/160/12,5/25 MG Each Tablet Contains: Amlopidine Besylate Equivalent to Amolodipine 10,0 mg; valsartan 160 mg; Hydrochlorothiazide 12,5 mg | 5/160/12,5/25 mgCo- | 48087748/7.1.3/0877 | Cancelled | Not determined | None |
| Co- dafiro 5/160/25,0 MG Each Tablet Contains: Amlopidine Besylate Equivalent to Amolodipine 5,0 mg; valsartan 160 mg: Hydrochlorothiazide 25,0 mg | 5/160/25,0 mgCo- | 48087848/7.1.3/0878 | Cancelled | Not determined | None |
| Co- dafiro 10/160/12,5mg Each Tablet Contains: Amlopidine Besylate Equivalent to Amolodipine 10,0 mg; valsartan 160 mg: Hydrochlorothiazide12,5 mg | 10/160/12,5mgCo- | 48087948/7.1.3/0879 | Cancelled | Not determined | None |
| Co- dafiro 10/320/25 MG Each Tablet Contains: Amlopidine Besylate Equivalent to Amolodipine 10,0 mg; valsartan 320 mg; Hydrochlorothiazide 25,0 mg | 10/320/25 mgCo- | 48088148/7.1.3/0881 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.